Last reviewed · How we verify
NCT03339063: IRENE
The Italian REgistry of Pulmonary Non-tuberculous mycobactEria
trial in Nontuberculous Mycobacteria in 500 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 21 April 2017 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 26 locations across Italy |
Conditions studied
- Nontuberculous Mycobacteria — all drugs for Nontuberculous Mycobacteria →
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Who can join
18 and older, any sex, with Nontuberculous Mycobacteria. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Italian registry of pulmonary non-tuberculous mycobacteria (NTM) -IRENE- is an observational, multicenter, prospective, cohort study enrolling consecutive adult patients with either a NTM respiratory infection or NTM-Pulmonary Disease. The coordinating center is located at the Pulmonary Department of the Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. So far, more than 35 centers, including mainly pulmonary and infectious disease departments, joined the registry. The registry has been developed to accept an unlimited number of patients and no deadlines have been decided.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.
Aliberti S, Codecasa LR, Gori A, Sotgiu G, et al · · 2018 · cited 9× · PMID 30151192 · DOI 10.1186/s40248-018-0141-8 -
Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA).
Kwak N, Choi H, Jeon D, Jhun BW, et al · · 2020 · cited 6× · PMID 32185919 · DOI 10.4046/trd.2019.0077 -
Clinical Trials involving <i>Mycobacterium abscessus</i>: An update.
Moore JE, Millar BC. · · 2025 · PMID 40313987
Verify or expand the search:
- PubMed search for NCT03339063
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nontuberculous Mycobacteria
Currently open trials in the same condition.
- NCT00814827 — Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to · active not recruiting
Other Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico trials
Trials by the same sponsor.
- NCT07492433 — Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR · not yet recruiting
- NCT07402174 — EIT- Guided Lung Recruitment in pARDS · NA · not yet recruiting
- NCT07234097 — The Influence of Music on perceiVed paIn and leVels of Anxiety whiLe unDergoing transperIneal Prostate Biopsy: the VIVAL · NA · not yet recruiting
- NCT07317193 — DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE · NA · recruiting
- NCT07487961 — Assess Abdominal Aortic Diameter in Females · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03339063 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Last refreshed: 26 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03339063.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing